Literature DB >> 31230441

A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.

K E Yoder.   

Abstract

The integrated proviral genome is the major barrier to a cure for HIV-1 infection. Genome editing technologies, such as CRISPR/Cas9, may disable or remove the HIV-1 provirus by introducing DNA double strand breaks at sequence specific sites in the viral genome. Host DNA repair by the error-prone non-homologous end joining pathway generates mutagenic insertions or deletions at the break. CRISPR/Cas9 editing has been shown to reduce replication competent viral genomes in cell culture, but only a minority of possible genome editing targets have been assayed. Currently there is no map of double strand break genetic fitness for HIV-1 to inform the choice of editing targets. However, CRISPR/Cas9 genome editing makes it possible to target double strand breaks along the length of the provirus to generate a double strand break genetic fitness map. We identified all possible HIV-1 targets with different bacterial species of CRISPR/Cas9. This library of guide RNAs was evaluated for GC content and potential off-target sites in the human genome. Complexity of the library was reduced by eliminating duplicate guide RNA targets in the HIV-1 long terminal repeats and targets in the env gene. Although the HIV-1 genome is AT-rich, the S. pyogenes CRISPR/Cas9 with the proto-spacer adjacent motif NGG offers the most HIV-1 guide RNAs. This library of HIV-1 guide RNAs may be used to generate a double strand break genetic fragility map to be further applied to any genome editing technology designed for the HIV-1 provirus. Keywords: HIV-1; genome editing; CRISPR; genetic fitness; guide RNAs.

Entities:  

Mesh:

Year:  2019        PMID: 31230441      PMCID: PMC6924169          DOI: 10.4149/av_2019_201

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  67 in total

Review 1.  Perspective: Evolution and detection of genetic robustness.

Authors:  J Arjan G M de Visser; Joachim Hermisson; Günter P Wagner; Lauren Ancel Meyers; Homayoun Bagheri-Chaichian; Jeffrey L Blanchard; Lin Chao; James M Cheverud; Santiago F Elena; Walter Fontana; Greg Gibson; Thomas F Hansen; David Krakauer; Richard C Lewontin; Charles Ofria; Sean H Rice; George von Dassow; Andreas Wagner; Michael C Whitlock
Journal:  Evolution       Date:  2003-09       Impact factor: 3.694

2.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

Review 3.  A guide to genome engineering with programmable nucleases.

Authors:  Hyongbum Kim; Jin-Soo Kim
Journal:  Nat Rev Genet       Date:  2014-04-02       Impact factor: 53.242

4.  Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.

Authors:  B Chesebro; K Wehrly
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

Review 5.  The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.

Authors:  Michael R Lieber
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

6.  Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells.

Authors:  B Chesebro; R Buller; J Portis; K Wehrly
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

8.  In vivo genome editing using Staphylococcus aureus Cas9.

Authors:  F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

9.  A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.

Authors:  Robert Jan Lebbink; Dorien C M de Jong; Femke Wolters; Elisabeth M Kruse; Petra M van Ham; Emmanuel J H J Wiertz; Monique Nijhuis
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

10.  Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.

Authors:  Rafal Kaminski; Yilan Chen; Tracy Fischer; Ellen Tedaldi; Alessandro Napoli; Yonggang Zhang; Jonathan Karn; Wenhui Hu; Kamel Khalili
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

View more
  3 in total

Review 1.  Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection.

Authors:  Alexandra Maslennikova; Dmitriy Mazurov
Journal:  Front Cell Infect Microbiol       Date:  2022-05-25       Impact factor: 6.073

2.  Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy.

Authors:  Cheng-Han Chung; Alexander G Allen; Andrew Atkins; Robert W Link; Michael R Nonnemacher; Will Dampier; Brian Wigdahl
Journal:  Front Cell Infect Microbiol       Date:  2021-03-09       Impact factor: 5.293

Review 3.  CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1.

Authors:  Amanda R Panfil; Patrick L Green; Kristine E Yoder
Journal:  Front Cell Infect Microbiol       Date:  2020-12-23       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.